PPP1R15A and cancer: Collectively, our studies indicate that the full-length or min-GADD34-Prom does not show cancer selectivity, and both mutations are required for achieving full cancer specificity in pGAPE, but these two mutations do not promote cancer selectivity when engineered into the pT-GADD (Figure 6C).